Education
About Us
Working with TipRanks
Follow Us
Liminatus Pharma (LIMN)
NASDAQ:LIMN
Liminatus Pharma (LIMN) Ownership Overview
The ownership structure of Liminatus Pharma (LIMN) stock is a mix of institutional, retail, and individual investors. , and 99.54% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 100,000 | Institution | 0.38% | 948,000 | |
| 73,424 | Institution | 0.27% | 143,911 | |
| 50,440 | Institution | 0.19% | 98,862 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 73,424 | Institution | 0.27% | 143,911 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 50,440 | Institution | 0.19% | 136,692 |
FAQ
Who Owns Liminatus Pharma (LIMN)?
Currently, no data Available
What percentage of Liminatus Pharma (LIMN) stock is held by institutional investors?
Currently, no data Available
What percentage of Liminatus Pharma (LIMN) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.54% of Liminatus Pharma (LIMN) stock is held by retail investors.
Who owns the most shares of Liminatus Pharma (LIMN)?
Louis Moore Bacon owns the most shares of Liminatus Pharma (LIMN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.